A guide to developing population files for physiologically-based pharmacokinetic modeling in the Simcyp Simulator

Area of Science:

• Pharmacokinetics and Drug Metabolism
• Computational Biology and Bioinformatics
• Pharmaceutical Sciences

Background:

• Physiologically-based pharmacokinetic (PBPK) modeling is crucial for predicting drug behavior.
• The Simcyp Simulator is a widely adopted software for stochastic PBPK modeling in the pharmaceutical industry.
• PBPK integrates in vitro data with biological parameters to predict pharmacokinetic changes in diverse populations.

Purpose of the Study:

• To provide a tutorial on creating virtual populations for PBPK modeling.
• To detail input parameters and model qualification for robust pharmacokinetic predictions.
• To illustrate PBPK application with case studies in specific patient groups.

Main Methods:

• Utilizing the Simcyp Simulator for PBPK modeling.
• Combining in vitro drug data with physiological and biological parameters.
• Developing population files for virtual populations, including case studies for obese and Crohn's disease patients.

Main Results:

• Demonstration of step-by-step population file development for specific patient groups.
• Highlighting considerations for qualifying PBPK models for various use contexts.
• Providing a framework for predicting pharmacokinetic changes in populations where clinical studies are not feasible.

Conclusions:

• PBPK modeling effectively predicts pharmacokinetic changes, filling gaps where clinical studies are impractical.
• The tutorial offers practical guidance for generating reliable virtual populations.
• This approach supports informed dosage adjustments and drug development strategies for diverse patient populations.